Abstract:Background: DNA Methylation is one of the most important epigenetic processes that are crucial to regulating the functioning of the human genome without altering the DNA sequence. DNA Methylation data for cancer patients are becoming more accessible than ever, which is attributed to newer DNA sequencing technologies, notably, the relatively low-cost DNA microarray technology by Illumina Infinium. This technology makes it possible to study DNA methylation at hundreds of thousands of different loci. Currently, most of the research found in the literature focuses on the discovery of DNA methylation markers for specific cancer types. A relatively small number of studies have attempted to find unified DNA methylation biomarkers that can diagnose different types of cancer (pan-cancer classification). Results: In this study, the aim is to conduct a pan-classification of cancer disease. We retrieved individual data for different types of cancer patients from The Cancer Genome Atlas (TCGA) portal. We selected data for many cancer types: Breast Cancer (BRCA), Ovary Cancer (OV), Stomach Cancer (STOMACH), Colon Cancer (COAD), Kidney Cancer (KIRC), Liver Cancer (LIHC), Lung Cancer (LUSC), Prostate Cancer (PRAD) and Thyroid cancer (THCA). The data was pre-processed and later used to build the required dataset. The system that we developed consists of two main stages. The purpose of the first stage is to perform feature selection and, therefore, decrease the dimensionality of the DNA methylation loci (features). This is accomplished using an unsupervised metaheuristic technique. As for the second stage, we used supervised machine learning and developed deep neural network (DNN) models to help classify the samples' malignancy status and cancer type. Experimental results showed that compared to recently published methods, our proposed system achieved better classification results in terms of recall, and similar and higher results in terms of precision and accuracy. The proposed system also achieved an excellent receiver operating characteristic area under the curve (ROC AUC) values varying from 0.85 to 0.89. Conclusions: This research presented an effective new approach to classify different cancer types based on DNA methylation data retrieved from TCGA. The performance of the proposed system was compared to recently published works, using different performance metrics. It provided better results, confirming the effectiveness of the proposed method for classifying different cancer types based on DNA methylation data.

A Hybrid Ensemble Approach for Identifying Robust Differentially Methylated Loci in Pan-Cancers

DNA Methylation Loci Identification for Pan-Cancer Early-Stage Diagnosis and Prognosis Using a New Distributed Parallel Partial Least Squares Method.

The Identification of Specific Methylation Patterns across Different Cancers

A new parsimonious method for classifying Cancer Tissue-of-Origin Based on DNA Methylation 450K data

Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis

Wemics: A Single‐Base Resolution Methylation Quantification Method for Enhanced Prediction of Epigenetic Regulation

Exploring Epigenetic Biomarkers of Universal Specificities and Commonalities among Pan-Cancer Cohorts in the Cancer Genome Atlas.

Identification of the Differential DNA Methylation Markers among Cancers

A hybrid metaheuristic-deep learning technique for the pan-classification of cancer based on DNA methylation

Identifying Differential Methylation in Cancer Epigenetics via a Bayesian Functional Regression Model

Identification of Functionally Methylated Regions Based on Discriminant Analysis Through Integrating Methylation and Gene Expression Data

DNA Methylation Markers for Pan-Cancer Prediction by Deep Learning

HMM-DM: identifying differentially methylated regions using a hidden Markov model

A Fragment-Based Algorithm for Identifying Pan-Cancer Differential Methylation Markers from Cfdna.

Tumor detection by analysis of both symmetric- and hemi-methylation of plasma cell-free DNA

Comparison of Different Normalization Assumptions for Analyses of Dna Methylation Data from the Cancer Genome

Screening Dys-Methylation Genes and Rules for Cancer Diagnosis by Using the Pan-Cancer Study

Detection of differentially methylated CpG sites between tumor samples with uneven tumor purities.

DNA Methylation Markers for Diagnosis and Prognosis of Common Cancers.

An analysis about heterogeneity among cancers based on the DNA methylation patterns

Discriminating Origin Tissues of Tumor Cell Lines by Methylation Signatures and Dys-Methylated Rules